Relugolix prostate (relugolix for prostate cancer)

Relugolix prostate (relugolix for prostate cancer) is filed as GnRH antagonist. The sections below restate public label fields stored for this profile.

Class
GnRH antagonist
Generic name
relugolix for prostate cancer
Dosage forms
Tablet

Common questions

What class of drug is Relugolix prostate?

Relugolix prostate (relugolix for prostate cancer) belongs to the GnRH antagonist class of medications.

Does Relugolix prostate have a Boxed Warning?

Our ingest of the FDA label for Relugolix prostate (relugolix for prostate cancer) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

Is Relugolix prostate currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Relugolix prostate (relugolix for prostate cancer) in our latest ingest. Recall data can change daily — verify at FDA.gov.

On this site

Other profiles with the same generic or brand name

Related medications in this class or category

Loading full data from Know Your Drugs Institute…